Erdosteine is a mucolytic active pharmaceutical ingredient. Following oral administration, it undergoes first-pass metabolism to form its active metabolite, which contains organosulfur groups responsible for its mucolytic activity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 84611-23-4
Itraconazole
pharmaceutical raw material
Lorcaserin hydrochloride
pharmaceutical raw material
Astragaloside IV
pharmaceutical raw material
2-(2,3-Dichlorophenyl)-2-guanidinyliminoacetonitrile
pharmaceutical raw material
DL-homocysteine thiolactone hydrochloride
pharmaceutical intermediate
2-[2-oxo-2-[(2-oxothiolan-3-yl)amino]ethyl]sulfanylacetic acid
QGFORSXNKQLDNO-UHFFFAOYSA-N
C1CSC(=O)C1NC(=O)CSCC(=O)O